Novel Targets for Old and Diseased Hearts
- PMID: 35743066
- PMCID: PMC9223834
- DOI: 10.3390/ijms23126627
Novel Targets for Old and Diseased Hearts
Abstract
In this Special Issue we cover a selection of original articles and reviews devoted to the definition of novel molecular targets in cardiovascular diseases, which not only deepen our knowledge on the pathogenesis of the diseases under study, but potentially pave the way to novel diagnostic tools and therapeutic approaches [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- D’Alessandra Y., Chiesa M., Vigorelli V., Ricci V., Rurali E., Raucci A., Colombo G.I., Pompilio G., Vinci M.C. Diabetes Induces a Transcriptional Signature in Bone Marrow-Derived CD34(+) Hematopoietic Stem Cells Predictive of Their Progeny Dysfunction. Int. J. Mol. Sci. 2021;22:1423. doi: 10.3390/ijms22031423. - DOI - PMC - PubMed
-
- Stadiotti I., Lippi M., Maione A.S., Compagnucci P., Andreini D., Casella M., Pompilio G., Sommariva E. Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms. Int. J. Mol. Sci. 2021;22:6500. doi: 10.3390/ijms22126500. - DOI - PMC - PubMed
-
- Barrachina M.N., Izquierdo I., Hermida-Nogueira L., Moran L.A., Perez A., Arroyo A.B., Garcia-Barbera N., Gonzalez-Conejero R., Troitino S., Eble J.A., et al. The PI3Kdelta Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. Int. J. Mol. Sci. 2021;22:3304. doi: 10.3390/ijms22073304. - DOI - PMC - PubMed